Skip to main content
TipRanks
Go Ultimate75% OFF

Biophytis (BPTSY) Drug Pipeline

41 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Semaglutide, Bio101, WegovyObesity, Obesity & Overweight, Muscle WastingPhase IINot Yet RecruitingTesting the Efficacy, Safety, and PK of 20E in Patients With Obesity Who Are Starting Treatment With the GLP-1 Agonist Semaglutide for Weight Loss.Feb 03, 2026
Bio101Covid-19, Sars-Cov2phase2AndPhase3TerminatedEfficacy and Safety of BIO101 in the Prevention of Respiratory Deterioration in Hospitalized COVID-19 PatientsJul 06, 2020―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Biophytis Sa (BPTSY) have in its pipeline
Biophytis BPTSY is currently developing the following drugs: Semaglutide, Bio101, Wegovy, Bio101. These drug candidates are in various stages of clinical development as the company works toward FDA approval.